
<!DOCTYPE html>
<html lang="en" data-theme="light">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>eMTCT & HIV in Pregnancy - Normal Midwifery</title>

    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap"
        rel="stylesheet">

    <!-- KaTeX for Math -->
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.css">
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.js"></script>
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/contrib/auto-render.min.js"></script>

    <link rel="stylesheet" href="../styles/main.css">
</head>

<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>

    <!-- Theme Toggle -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <!-- Floating Quiz Button -->
    <a href="#topic-quiz" class="floating-quiz-btn" aria-label="Jump to quiz">
        <span class="quiz-btn-icon">üìù</span>
        <span class="quiz-btn-text">Take Quiz</span>
    </a>

    <!-- Reading Progress -->
    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">

                <!-- TOP NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="topic-03.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>

                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Index</span>
                        </a>

                        <a href="../quiz-hub.html" class="nav-button nav-button--quiz">
                            <span class="nav-icon">üìù</span>
                            <span class="nav-text">All Quizzes</span>
                        </a>

                        <a href="topic-05.html" class="nav-button nav-button--next">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 50%;"></div>
                        </div>
                        <span class="progress-text">Topic 4 of 8</span>
                    </div>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span>üß¨</span>
                        <span>Topic 04</span>
                    </div>
                    <h1 class="document-title">eMTCT & HIV in Pregnancy</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>HIV Biology, Staging, Testing & eMTCT Protocols</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>30 min read</span>
                        </div>
                        <div class="meta-item meta-item--quiz">
                            <span>üìù</span>
                            <a href="#topic-quiz">Quiz Available</a>
                        </div>
                    </div>
                </header>

                <!-- Main Content -->
                <main id="main-content" class="content-wrapper">

                    <!-- Section 1: Overview and Biology -->
                    <section class="content-section" id="section-1">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü¶†</span>
                                Overview and Biology of HIV
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>HIV (Human Immunodeficiency Virus) is a retrovirus in the family of Lentivirus.</p>
                            <p>Its genetic material consists of a single-stranded ribonucleic acid (RNA)</p>
                            <p>The viral particle is spherical in shape with a diameter of 80-100 nanometers (nm).</p>
                            
                            <h4>Types of HIV</h4>
                            <p>There are two types of HIV, namely:</p>
                            
                            <ul class="enhanced-list">
                                <li>
                                    <strong>HIV ‚Äì 1</strong>
                                    <ul>
                                        <li>It is found worldwide</li>
                                        <li>It is the main cause of the worldwide pandemic</li>
                                        <li>HIV-1 has many subtypes: A-K. A-E are the predominant subtypes.
                                            <ul>
                                                <li>A: -W. Africa, E. Africa, Central Africa East Europe & Middle East</li>
                                                <li>B: -N. America, Europe, Middle East, E. Asia, Latin America</li>
                                                <li>C:- S. Africa, S. Asia, Ethiopia</li>
                                                <li>D:- E. Africa</li>
                                                <li>E:- S. E. Asia</li>
                                            </ul>
                                        </li>
                                    </ul>
                                </li>
                                <li>
                                    <strong>HIV ‚Äì 2</strong>
                                    <ul>
                                        <li>It is mainly found in West Africa, Mozambique and Angola.</li>
                                        <li>It causes a similar illness to HIV ‚Äì 1</li>
                                        <li>It is less efficiently transmissible rarely causing vertical transmission</li>
                                        <li>Less aggressive with slower disease progression</li>
                                    </ul>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3>Structure Of Human Immunodeficiency Virus</h3>
                            <ul class="enhanced-list">
                                <li>Has an outer double lipid membrane, (derived from the host membrane).</li>
                                <li>The lipid membrane is lined by a matrix protein.</li>
                                <li>The lipid membrane is studded with the surface glycoprotein (gp) 120 and the transmembrane gp 41 protein.</li>
                                <li>These glycoprotein spikes surround the cone-shaped protein core.</li>
                                <li>HIV Glycoproteins: that is, gp120 and gp41 mediate the entry of virus into the host cells.</li>
                                <li>The core (capsid) is made up of several proteins with P24 being the main protein. Within the capsid are two identical single strands of RNA (the viral genetic material) and viral enzymes.</li>
                            </ul>

                            <figure class="content-figure">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20260128-a0a7a559.jpeg" alt="Structure of HIV Virus" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to zoom</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Figure: Structure Of Human Immunodeficiency Virus</figcaption>
                            </figure>

                            <ul class="enhanced-list">
                                <li>Most important: Reverse Transcriptase (RT), Protease and Integrase.</li>
                                <li>RT converts viral single-stranded RNA into a double stranded deoxyribonucleic acid (DNA). DNA is incorporated into host nucleus as the proviral DNA.</li>
                                <li>Integrase facilitates integration of the DNA into the host's chromosomal DNA.</li>
                                <li>Protease enzyme splits generated macro-proteins into smaller viral proteins (core, envelope & regulatory proteins and enzymes) which go into forming new viral particles.</li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3>HIV life cycle</h3>
                            <p>HIV life cycle has the following stages: -</p>
                            <ol class="enhanced-list">
                                <li>Binding, Fusion and Entry</li>
                                <li>Transcription</li>
                                <li>Integration & Replication</li>
                                <li>Budding</li>
                                <li>Maturation</li>
                            </ol>

                            <h4>Binding:</h4>
                            <ul class="enhanced-list">
                                <li>Glycoprotein GP 120 binds to the host cell surface receptor (CD4 molecule) and coreceptor (CCR5/CXCR4) for successful entry.</li>
                                <li>Can also bind to CXCR2, CXCR3 and hitch ride on B-cells to lymph nodes.</li>
                            </ul>

                            <h4>Fusion and Entry:</h4>
                            <ul class="enhanced-list">
                                <li>Viral binding to host cell triggers fusion of the viral and host cell membranes. This mediated by gp41</li>
                                <li>Allows entry of virus core into host cell cytoplasm</li>
                                <li>Core protein dissolved by host enzymes releasing viral RNA and enzymes</li>
                            </ul>

                            <h4>Transcription & Integration</h4>
                            <ul class="enhanced-list">
                                <li>Reverse transcriptase converts the viral RNA into a single strand of DNA</li>
                                <li>RT also acts as a DNA polymerase to produce a partner strand of DNA to match the original template resulting in a double stranded DNA (dsDNA) but no proof-reading ability</li>
                                <li>The DNA enters the host cell nucleus</li>
                                <li>Integrase catalyses the process of integration of the viral DNA into the host cell's DNA to form provirus</li>
                            </ul>

                            <h4>Replication</h4>
                            <p>Integrated viral DNA turns the host cell into a "factory" for manufacturing more virus.</p>
                            <p>Viral proteins are produced as a single multi-protein molecule. Viral proteins cleaved by protease enzyme</p>

                            <h4>Budding and Maturation:</h4>
                            <ul class="enhanced-list">
                                <li>Viral proteins together with RNA gather at the membrane of the CD4+ cells</li>
                                <li>Viral particles are formed which bud off the cell and enter the bloodstream</li>
                            </ul>
                            <p>The CD4 cells are often destroyed by HIV virus infection and replication resulting in profound immunodeficiency.</p>

                            <figure class="content-figure">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20260128-cb04c9d3.jpeg" alt="HIV Life Cycle Summary" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to zoom</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Figure: HIV Life Cycle Summary</figcaption>
                            </figure>
                        </div>
                    </section>

                    <!-- Section 2: Natural History & Staging -->
                    <section class="content-section" id="section-2">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìà</span>
                                Natural History & Clinical Staging
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Natural History of HIV Infection</h3>
                            <p>The natural history of HIV infection has the following stages: -</p>
                            
                            <h4>a) Primary infection (sero-conversion)</h4>
                            <p>On exposure, there is a 2-4 week period of intense viral replication and widespread dissemination of virus characterized by</p>
                            <ul class="enhanced-list">
                                <li>High plasma viral load (RNA)</li>
                                <li>Rapid decline in CD4 count</li>
                            </ul>
                            <p>In some cases an acute illness occurs. Lasts from 1-2 weeks, but it is rarely diagnosed. Symptoms if present resemble those of other viral illnesses; requires high index of suspicion.</p>
                            <p>Symptom resolution with reduction in plasma viremia due to development of an immune response and antibodies to the virus</p>

                            <h4>b) Asymptomatic Disease (Latency) stage</h4>
                            <p>Patients then enter a stage of asymptomatic disease phase lasting on average 2-10 years (clinical latency)</p>
                            <p>Characterized by gradual decline in CD4 count. Rate depends on viral load</p>

                            <h4>c) Symptomatic stage</h4>
                            <p>Viral load continues to rise causing:</p>
                            <ul class="enhanced-list">
                                <li>Increased demands on immune system as production of CD4 cells cannot match destruction</li>
                                <li>Increased susceptibility to common infections (URTI, pneumonia, skin etc)</li>
                            </ul>

                            <h4>d) Progression of HIV infection to AIDS</h4>
                            <p>This is Late-stage of HIV progression characterized by markedly reduction in CD4 count and the development of opportunistic infections, selected tumors, wasting, and neurological complications.</p>
                            <p>It signals progression of HIV infection to Acquired Immune deficiency syndrome.</p>
                        </div>

                        <div class="content-card">
                            <h3>WHO Clinical Staging of HIV infection</h3>
                            <div class="table-wrapper">
                                <table class="content-table">
                                    <thead>
                                        <tr>
                                            <th>Clinical Stage</th>
                                            <th>Selected Symptoms</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Primary HIV Infection</strong></td>
                                            <td>
                                                1. Unrecognized Acute retroviral syndrome<br>
                                                2. Acute febrile illness 2-4 wks post-exposure often with lymphadenopathy and skin manifestations
                                            </td>
                                        </tr>
                                        <tr>
                                            <td><strong>Stage I</strong></td>
                                            <td>
                                                1. Asymptomatic<br>
                                                2. Persistent generalized lymphadenopathy
                                            </td>
                                        </tr>
                                        <tr>
                                            <td><strong>Stage II</strong></td>
                                            <td>
                                                1. Moderate unexplained weight loss (&lt;10% of presumed or measured body weight)<br>
                                                2. Recurrent upper respiratory tract infections (sinusitis, bronchitis, otitis media, pharyngitis)<br>
                                                3. Herpes zoster (past or current episodes in last 2 years)<br>
                                                4. Angular cheilitis<br>
                                                5. Recurrent oral ulcerations (2 or more episodes in 6 months)<br>
                                                6. Papular pruritic eruptions; Seborrhoeic dermatitis; Fungal nail infections of fingers
                                            </td>
                                        </tr>
                                        <tr>
                                            <td><strong>Stage III</strong></td>
                                            <td>
                                                <strong>Conditions where a presumptive diagnosis can be made using clinical signs or simple investigations:</strong><br>
                                                - Severe weight loss (&gt;10% presumed or measured body weight)<br>
                                                - Unexplained chronic diarrhea for &gt; 1 month<br>
                                                - Unexplained persistent fever (intermittent or constant for &gt; 1 month)<br>
                                                - Persistent oral candidiasis<br>
                                                - Oral hairy leukoplakia<br>
                                                - Pulmonary tuberculosis<br>
                                                - Severe bacterial infections (e.g. pneumonia, empyema, pyomyositis, bone or joint infection, meningitis or bacteremia)<br>
                                                - Acute necrotizing ulcerative stomatitis, gingivitis or periodontitis<br>
                                                - Unexplained anemia (&lt;8g/dl), neutropenia (&lt;0.5x10^9/L) and or chronic thrombocytopenia (&lt;50 x 10^9/L)
                                            </td>
                                        </tr>
                                        <tr>
                                            <td><strong>Stage IV</strong></td>
                                            <td>
                                                <strong>Conditions where a presumptive diagnosis can be made using clinical signs or simple investigations:</strong><br>
                                                - HIV wasting syndrome<br>
                                                - Pneumocystis carinii pneumonia (PCP)<br>
                                                - Recurrent severe bacterial pneumonia<br>
                                                - Cryptococcal meningitis<br>
                                                - Toxoplasmosis of the brain<br>
                                                - Chronic orolabial, genital or anorectal herpes simplex infection for &gt; 1 month<br>
                                                - Kaposi‚Äôs sarcoma (KS)<br>
                                                - HIV encephalopathy<br>
                                                - Extrapulmonary tuberculosis<br>
                                                - Cryptosporidiosis, with diarrhea &gt;1 month<br>
                                                - Isosporiasis<br>
                                                <strong>Conditions where confirmatory diagnostic testing is necessary:</strong><br>
                                                - Candidiasis of the esophagus or airways<br>
                                                - Cytomegalovirus (CMV) retinitis or disease of organs (other than liver, spleen, or lymph nodes)<br>
                                                - Non-typhoid salmonella septicemia (NTS)<br>
                                                - Lymphoma cerebral or B cell NHL<br>
                                                - Invasive cervical carcinoma<br>
                                                - Visceral Leishmaniasis<br>
                                                - Cryptococcosis (extrapulmonary)<br>
                                                - Disseminated non tuberculous mycobacterial infection<br>
                                                - Progressive multifocal leukoencephalopathy<br>
                                                - Any disseminated endemic mycosis (e.g. histoplasmosis)
                                            </td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </section>

                    <!-- Section 3: HIV Testing -->
                    <section class="content-section" id="section-3">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß™</span>
                                HIV Testing
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>The importance of HIV testing includes:</h3>
                            <ul class="enhanced-list">
                                <li>Diagnosis of HIV.</li>
                                <li>To enable Staging of HIV disease (especially through CD4 T cell analysis)</li>
                                <li>To determine the prognosis of HIV infection (mainly through CD4 T cell analysis and viral load)</li>
                                <li>To determine when to initiate preventive therapies and ART(CD4 T cell analysis)</li>
                                <li>To assess response to ART (CD4 T cell analysis/viral load)</li>
                                <li>To evaluate patients for toxicity to ARVs (RFT/LFT)</li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3>Approaches in HIV testing</h3>
                            <p>The following approaches are applied in HIV Testing.</p>
                            <ol class="enhanced-list">
                                <li>Voluntary counseling and testing</li>
                                <li>Diagnostic HIV testing</li>
                                <li>Provider initiated counseling and testing</li>
                                <li>Mandatory HIV testing and screening</li>
                            </ol>
                        </div>

                        <div class="content-card">
                            <h3>Types of HIV tests</h3>
                            <p>Types of HIV tests are classified into two, namely:</p>
                            
                            <h4>a) Antibody based test</h4>
                            <ul class="enhanced-list">
                                <li>Enzyme Immunosorbent Assay (ELISA)</li>
                                <li>Western Blot</li>
                                <li>Rapid Tests</li>
                            </ul>

                            <h4>b) Viral detection methods/ antigen based tests</h4>
                            <ul class="enhanced-list">
                                <li>PCR</li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3>Rapid HIV tests (RDTs)</h3>
                            <ul class="enhanced-list">
                                <li>They were developed in the late 1980s</li>
                                <li>They can be performed in less than 20 minutes</li>
                                <li>It can be performed easily without sophisticated instruments.</li>
                                <li>Results are available immediately.</li>
                                <li>Examples ‚Äì Determine, First response and Oraquick.</li>
                            </ul>
                            <p>The learner should note that HIV testing approaches is highly dynamic hence one should keep updated from time to time.</p>
                            <p>Oraquick is designed for self-testing.</p>
                        </div>
                    </section>

                    <!-- Section 4: eMTCT Framework -->
                    <section class="content-section" id="section-4">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üë©‚Äçüçº</span>
                                eMTCT Framework
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Elimination of Mother to Child Transmission of HIV(eMTCT)</h3>
                            <p>eMTCT can be defined as measures and interventions put in place to avert transmission of HIV from the mother to the baby.</p>
                            <p>It was formerly referred as PMTCT (Prevention of Mother to Child Transmission of HIV), However it changed to eMTCT that endeavours to achieve zero transmission of HIV to babies.</p>
                            
                            <h4>Mother to Child Transmission rates:</h4>
                            <ul class="enhanced-list">
                                <li>During pregnancy 5-10%</li>
                                <li>During labour and delivery 10-20%</li>
                                <li>During breastfeeding 5-20%</li>
                            </ul>

                            <h4>BENEFITS OF Emtct</h4>
                            <ul class="enhanced-list">
                                <li>Improved child health and child survival</li>
                                <li>Decreased burden to the health care system</li>
                                <li>Increased public understanding of the HIV/AIDS epidemic</li>
                                <li>Help increase acceptance of people living with HIV/AIDS</li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3>FOUR PILLARS OF W.H.O TO REDUCE MTCT</h3>
                            <ol class="enhanced-list">
                                <li>Preventing of unintended pregnancy in HIV+ women through family planning.</li>
                                <li>Prevention of HIV infection in women through use of ABCD</li>
                                <li>eMTCT in pregnancy: testing and counselling to identify HIV+ women; provide ARVS to mother and baby; use of infection prevention practices.</li>
                                <li>Care and support to those living with HIV/AIDS.</li>
                            </ol>
                        </div>

                        <div class="content-card">
                            <h3>Four Pronged approach to eMTCT</h3>
                            <p>The four prongs of eMTCT are:</p>
                            <ol class="enhanced-list">
                                <li>Primary prevention of HIV infection in women.</li>
                                <li>Prevention of unintended pregnancies among HIV-infected women.</li>
                                <li>Interventions to reduce transmission from HIV infected and lactating women to their children.</li>
                                <li>Care and support of women, children and families infected and affected by HIV and AIDS(eMTCT-Plus).</li>
                            </ol>
                        </div>
                    </section>

                    <!-- Section 5: Pregnancy & HIV Interactions -->
                    <section class="content-section" id="section-5">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü§∞</span>
                                Pregnancy & HIV Interactions
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Effects of pregnancy on HIV-AIDS</h3>
                            <ul class="enhanced-list">
                                <li>Immune response is suppressed</li>
                                <li>CD4 counts decline more rapidly compared to non-pregnant women</li>
                                <li>At increased risk of UTI</li>
                                <li>It may accelerate the progress to full blown AIDS or quicker deterioration if the final stage of AIDS.</li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3>Effects of HIV-AIDS on the pregnancy</h3>
                            <ul class="enhanced-list">
                                <li>Associated with other STIs</li>
                                <li>They are more likely to have candidal vaginitis</li>
                                <li>Increase of other infections e.g UTIs</li>
                                <li>Rate of ectopic pregnancy is 4 times higher in HIV +ve women.</li>
                                <li>Higher rates of abortions and stillbirths have been reported in some African studies</li>
                                <li>Preterm labour and PPROM</li>
                                <li>Higher rate of abruptio placenta in HIV +ve women.</li>
                                <li>Chorio-amniotis is more common in women with HIV infection.</li>
                                <li>HIV is a major cause of anaemia in pregnancy.</li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3>Risk factor for Mother To Child Transmission OF HIV</h3>
                            
                            <h4>a) Viral factor</h4>
                            <ul class="enhanced-list">
                                <li>Clinical stage of infection: new and advanced infections</li>
                                <li>High viral load in blood and genital tract</li>
                            </ul>

                            <h4>b) Maternal factors</h4>
                            <ul class="enhanced-list">
                                <li>Low maternal CD4 count (the number of cells per cubic millimetre of blood)</li>
                                <li>Vitamin A Deficiency</li>
                                <li>Unprotected sex with multiple and infected partners</li>
                                <li>STIs and other co infections</li>
                                <li>Mother not taking ARV agents</li>
                                <li>Malaria infection in pregnant women.</li>
                                <li>Breast infections or disorders.</li>
                            </ul>

                            <h4>c) Obstetric and gynaecological factors</h4>
                            <ul class="enhanced-list">
                                <li>Invasive foetal monitoring procedures</li>
                                <li>Duration of membrane rupture</li>
                                <li>Routine episiotomy</li>
                                <li>Placental disruption</li>
                                <li>Vaginal delivery</li>
                                <li>Prolonged labour.</li>
                            </ul>

                            <h4>d) Infant factors</h4>
                            <ul class="enhanced-list">
                                <li>Breastfeeding (longer duration of breastfeeding)</li>
                                <li>Preterm delivery</li>
                                <li>Neonatal birth injuries</li>
                                <li>Vigorous naso-gastric tube suction</li>
                                <li>Infections eg oral ulcers or thrush.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 6: HTC in eMTCT -->
                    <section class="content-section" id="section-6">
                        <div class="section-header">
                            <div class="section-number">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">üó£Ô∏è</span>
                                HTC in eMTCT
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>HIV Testing and Counselling in eMTCT</h3>
                            <h4>Definition of terms</h4>
                            <p><strong>a) HIV testing:</strong> process of determining if client is infected with HIV</p>
                            <p><strong>b) HIV counselling:</strong> confidential dialogue between an individual or a couple and a healthcare worker (HCW) to help clients examine their risk of acquiring or transmitting HIV. HIV counselling should be tailored to the risk behaviour, circumstances and special needs of the client</p>
                            
                            <h4>HIV Testing and Counselling in eMTCT provides:</h4>
                            <ul class="enhanced-list">
                                <li>Information about HIV status</li>
                                <li>Opportunity to identify women with HIV and empower them to make decisions to prevent MTCT</li>
                                <li>Opportunity to identify women who are HIV negative and empower them to remain negative</li>
                            </ul>

                            <h4>Principles of HIV testing and counselling:</h4>
                            <ol class="enhanced-list">
                                <li>Confidentiality</li>
                                <li>Informed consent</li>
                                <li>Post-test support and services</li>
                            </ol>
                        </div>

                        <div class="content-card">
                            <h3>Steps in HIV Testing</h3>
                            <ol class="enhanced-list">
                                <li>A specimen is obtained</li>
                                <li>The specimen is processed</li>
                                <li>Test is conducted by a HCW or laboratory technician</li>
                                <li>The client is told their result</li>
                                <li>HCW provides post-test counselling, support and appropriate referrals</li>
                            </ol>

                            <h4>When performing HIV testing, you are required to observe the following points:</h4>
                            <ul class="enhanced-list">
                                <li>Infection control and Standard Precautions</li>
                                <li>Proper labelling</li>
                                <li>Proper specimen collection procedures</li>
                                <li>Required volume per test</li>
                                <li>Proper reagents per test</li>
                                <li>Correct timing per test</li>
                                <li>Interpretation of results</li>
                                <li>Proper record-keeping</li>
                                <li>Proper disposal procedures</li>
                            </ul>

                            <h4>Factors that can affect test results</h4>
                            <ul class="enhanced-list">
                                <li>Storage and handling of test kits</li>
                                <li>Changes in the environment</li>
                                <li>Accuracy of equipment (external and internal controls)</li>
                                <li>Shelf-life of the chemicals for the tests (reagents)</li>
                                <li>Technique for sample collection</li>
                                <li>Quality of sample</li>
                                <li>Use of equipment</li>
                            </ul>

                            <figure class="content-figure">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20260128-f9b3a92e.jpeg" alt="Factors affecting test results" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to zoom</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Figure: Factors affecting test results</figcaption>
                            </figure>
                        </div>

                        <div class="content-card">
                            <h3>Post-test Counselling</h3>
                            <p>All HIV test results, whether positive or negative, must be given in person, privately (as a single client or couple). Put the client or couple at ease. Remember that client can either turn negative or positive.</p>

                            <h4>When Client Tests HIV-negative</h4>
                            <ul class="enhanced-list">
                                <li>Provide HIV test result and assess understanding of result</li>
                                <li>Identify and address client questions</li>
                            </ul>
                            <p><strong>Discuss:</strong></p>
                            <ul class="enhanced-list">
                                <li>Partner HIV testing and disclosure</li>
                                <li>Safer sex and risk reduction</li>
                                <li>Exclusive breastfeeding</li>
                                <li>Antenatal care, post-delivery care</li>
                                <li>Importance of delivering in a healthcare facility</li>
                                <li>Infant care</li>
                            </ul>
                            <p>Provide referrals, take-home information</p>

                            <h4>When Client Tests HIV-positive</h4>
                            <ul class="enhanced-list">
                                <li>Client reactions to results can range from acceptance to disbelief</li>
                                <li>Remain non-judgemental, supportive and confident throughout the counselling process</li>
                                <li>Provide all key eMTCT messages during the initial post-test counselling session</li>
                                <li>Encourage client to return for her ANC visits and follow-up HIV post-test counselling</li>
                            </ul>
                            <p><strong>Discuss:</strong></p>
                            <ul class="enhanced-list">
                                <li>ARV therapy or prophylaxis</li>
                                <li>Infant feeding options</li>
                                <li>Treatment and support services for client and family</li>
                            </ul>

                            <h4>Disclosure of HIV Status</h4>
                            <p>Clients who disclose are in a better position to:</p>
                            <ul class="enhanced-list">
                                <li>Encourage partner(s) to be tested</li>
                                <li>Prevent transmission of HIV to partner(s)</li>
                                <li>Access PMTCT interventions</li>
                                <li>Receive support from partner(s) and family</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 7: Management Protocols -->
                    <section class="content-section" id="section-7">
                        <div class="section-header">
                            <div class="section-number">07</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Management Protocols
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Management of HIV positive clients during pregnancy</h3>
                            <p>As discussed earlier during FANC, the midwife should:</p>
                            <ul class="enhanced-list">
                                <li>Provide Primary prevention services during pregnancy such as, Education about safer sex with use of condoms for mother and father, Early treatment of STIs, Safer sex during pregnancy and lactation</li>
                                <li>Ensure VCT services are offered to all pregnant women.</li>
                                <li>Understand that Antenatal visits are vital opportunities for eMTCT for both HIV-positive and HIV-negative women.</li>
                                <li>Every pregnant woman should be offered HIV testing.</li>
                                <li>HIV testing should be voluntary.</li>
                                <li>eMTCT depends on being able to identify women who can benefit from interventions.</li>
                            </ul>

                            <h4>Care of HIV Positive women in FANC</h4>
                            <p>Initial assessment should be conducted on HIV positive pregnant women, and should include:</p>
                            <ul class="enhanced-list">
                                <li>Duration of known HIV+ status</li>
                                <li>Past history of HIV-related illness and HAART</li>
                                <li>WHO Staging</li>
                                <li>Status of other children, partner, and partner disclosure and referral</li>
                                <li>Any medications taken for HIV-related illness since beginning of pregnancy</li>
                                <li>Women with HIV should have medical care during pregnancy</li>
                                <li>Look for and treat other infections such as malaria, anemia etc</li>
                                <li>Nutritional counselling and supplements</li>
                                <li>Monitor the HIV infection</li>
                                <li>Counselling about infant feeding, other infections, danger signs etc</li>
                                <li>Counsel the mother on birth preparedness.</li>
                                <li>Early detection of opportunistic infections.</li>
                                <li>Provide prophylactic(preventive) intervention such IFAS, Tetanus Toxoid, use of LLITNs, cotrimoxazole(Septrin) prophylaxis.</li>
                            </ul>

                            <h4>Antiretroviral treatment</h4>
                            <ul class="enhanced-list">
                                <li>All pregnant women irrespective of CD4 Count or Viral load should be initiated on HAART immediately.</li>
                                <li>HAART (Highly Active Antiretroviral Therapy) is a treatment regimen comprising of a combination of three or more antiretroviral drugs. This co-administration of different drugs helps in suppressing viral replication through several mechanisms.</li>
                                <li>The current HAART regimen used in Kenya is a combination of tdf(tenofovir)+3tc(Lamivudine)+efv (efavirenz).</li>
                                <li>All HIV positive pregnant women should be started on Cotrimoxazole (Septrin) prophylaxis to protect the mother from bacterial opportunistic infections.</li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3>Management during labour</h3>
                            <p>Management during labour and delivery should include:</p>
                            
                            <h4>Antiretroviral therapy</h4>
                            <p>The mother should continue with HAART and ctx as prescribed.</p>

                            <h4>The following procedures should be avoided in order to prevent injury to the foetus:</h4>
                            <ul class="enhanced-list">
                                <li>Artificial rupture of membranes</li>
                                <li>Scalp electrodes</li>
                                <li>Amnioinfusion</li>
                                <li>Amniocentesis</li>
                                <li>Forceps and vacuum delivery</li>
                                <li>Oropharngeal suctioning of the new-born to prevent injury to the mucosa</li>
                            </ul>

                            <h4>Prevention of contamination with maternal blood and fluids</h4>
                            <ul class="enhanced-list">
                                <li>Perineal trauma and episiotomies should be avoided</li>
                                <li>Baby should be wiped immediately after birth.</li>
                                <li>Perform immediate clamping and cutting of the cord.</li>
                            </ul>

                            <h4>Prevention of intrauterine contamination with vaginal secretion</h4>
                            <ul class="enhanced-list">
                                <li>Shorten length of ruptured membranes to less than 4 hours</li>
                                <li>Limit the number of vagina examination (Avoid too many unnecessary Vaginal examinations).</li>
                            </ul>

                            <h4>Prevent and treat other infections and complications</h4>
                            <p>Check for and manage UTIs at the start of labour</p>

                            <h4>Monitor labour carefully using partograph</h4>
                            <p>Using a partograph will enable the midwife to detect any complication during labour.</p>

                            <h4>Caesarean section</h4>
                            <p>Evaluate and consider Caesarean Section. Available evidence shows that Caesarean Section reduces incidence of HIV transmission to the baby.</p>
                        </div>

                        <div class="content-card">
                            <h3>Management during postpartum</h3>
                            <p>During post-natal period, the care now focusses both to the mother and the baby. In addition to immediate maternal care after delivery, the mother should: -</p>
                            <ul class="enhanced-list">
                                <li>Continue and Adhere to HAART and ctx</li>
                                <li>Advised and counsel of appropriate contraception and child spacing.</li>
                                <li>Advised on feeding options:
                                    <ul>
                                        <li><strong>Exclusive breastfeeding:</strong> reduces the chance of HIV transmission to the baby. Breastfeeding should be exclusive for 6 months, if breastfeeding is chosen teach the mother good breastfeeding technique to avoid cracked nipples and mastitis which can increase MTCT. Mixed feeding, presence of mastitis and cracked nipples increases the risk of HIV transmission.</li>
                                        <li><strong>Formula feeding:</strong> AFASS criteria to see if mother is able to follow exclusive formula feeding (EFF) is used:
                                            <ul>
                                                <li>Acceptability: is EFF acceptable for the mother</li>
                                                <li>Feasibility: is the mother able to begin EFF correctly for the required period</li>
                                                <li>Affordability: is the mother able to afford the cost of EFF</li>
                                                <li>Sustainability: will the mother be able to continue the recommended EFF standards for the required period</li>
                                                <li>Safety: will the mother be able to practice EFF safely</li>
                                            </ul>
                                        </li>
                                    </ul>
                                </li>
                            </ul>

                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ÑπÔ∏è</span>
                                    <h4 class="callout-title">Care of HIV-Exposed Infant (HEI)</h4>
                                </div>
                                <div class="callout-content">
                                    <p>In addition to essential new-born care, care of HIV-Exposed Infant (HEI) should also include:-</p>
                                    <ul class="enhanced-list">
                                        <li>Initiation of Nevirapine at birth up to 12 weeks as per the baby‚Äôs weight.</li>
                                        <li>Nevirapine should be issued to the HIV positive mother at the first point of contact for the baby in case she delivers before reaching the hospital.</li>
                                        <li>Nevirapine therapy to the baby should be started at birth or at the first contact with the exposed infant.</li>
                                        <li>Infant prophylaxis with Nevirapine syrup should up to 12 weeks from birth for mothers on HAART</li>
                                        <li>Infant prophylaxis with Nevirapine syrup should up to one week after cessation of breast feeding for mothers not on HAART.</li>
                                        <li>Initiation of Zidovudine (Syrup) at birth up to six weeks.</li>
                                        <li>After 12 weeks Nevirapine is stopped.</li>
                                        <li>The baby is put on Cotrimoxazole (Septrin) syrup from 6 weeks up to 18 months.</li>
                                    </ul>
                                </div>
                            </div>

                            <h4>Infant Testing</h4>
                            <p>Infant PCR testing (Using Dry Blood Spots technique) is done at 6 weeks after birth, then 6 months after birth, the third is done at one year after birth and fourth and the last is done at 18 months after birth.</p>
                            <p>PCR result at 18 months is considered final.</p>
                            <p>Immunization schedule of HIV Exposed Infant (HEI) is similar to the national immunization schedule, however these infants receives a booster measles vaccine at 6 months in their life.</p>

                            <figure class="content-figure">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20260128-4ec03e6b.jpeg" alt="Algorithm for Early Infant Diagnosis" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to zoom</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Figure 2.1 Algorithm for Early Infant Diagnosis in Infants and Children &lt; 18 months of age</figcaption>
                            </figure>
                        </div>

                        <div class="content-card">
                            <h3>Summary of infant Nevirapine prophylaxis</h3>
                            <div class="table-wrapper">
                                <table class="content-table">
                                    <thead>
                                        <tr>
                                            <th>Age</th>
                                            <th>NVP Dose</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td>0-6 weeks</td>
                                            <td>Birth weight &lt;2500gm-10mg (1ml)- OD<br>Birth weight &gt;2500gm-15mg (1.5 mls)- OD</td>
                                        </tr>
                                        <tr>
                                            <td>6-14 weeks</td>
                                            <td>20mg (2mls)- OD</td>
                                        </tr>
                                        <tr>
                                            <td>14wks-6months</td>
                                            <td>25mg (2.5mls)- OD</td>
                                        </tr>
                                        <tr>
                                            <td>6-9 months</td>
                                            <td>30mg (3mls)- OD</td>
                                        </tr>
                                        <tr>
                                            <td>9-12 months</td>
                                            <td>40mg (4mls)- OD</td>
                                        </tr>
                                        <tr>
                                            <td>&gt;12 months</td>
                                            <td>50mg (5mls)- OD</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>

                        <div class="content-card">
                            <h3>Summary of HIV Exposed Infant Cotrimoxazole prophylaxis</h3>
                            <div class="table-wrapper">
                                <table class="content-table">
                                    <thead>
                                        <tr>
                                            <th>Weight (Kgs)</th>
                                            <th>Suspension 240mg/5mls</th>
                                            <th>Single strength 480mg</th>
                                            <th>tab Double strength 960mg</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td>1-4</td>
                                            <td>2.5 mls</td>
                                            <td>¬º</td>
                                            <td></td>
                                        </tr>
                                        <tr>
                                            <td>5-8</td>
                                            <td>5.0 mls</td>
                                            <td>¬Ω</td>
                                            <td>¬º</td>
                                        </tr>
                                        <tr>
                                            <td>9-16</td>
                                            <td>10 mls</td>
                                            <td>1</td>
                                            <td>¬Ω</td>
                                        </tr>
                                        <tr>
                                            <td>17-30</td>
                                            <td>15 mls</td>
                                            <td>2</td>
                                            <td>1</td>
                                        </tr>
                                        <tr>
                                            <td>&gt;30</td>
                                            <td></td>
                                            <td>2</td>
                                            <td>1</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ÑπÔ∏è</span>
                                    <h4 class="callout-title">NB</h4>
                                </div>
                                <div class="callout-content">
                                    <p>AZT(10mg/kg) BD if the infant weight is &lt;2500g or 15mg/kg BD if the infant weight is &gt;2500g is an alternative for infants on TB treatment of Nevirapine toxicity.</p>
                                    <p>3TC (2mg/kg) BD if the baby is below 4 weeks of age and 4mg/kg BD if the infant is over 4 weeks of age is an alternative for infant with severe Nevirapine toxicity or if the baby is on TB treatment with Rifampicin containing regimen.</p>
                                    <p>Mothers who were not tested for HIV during antenatal period can be counselled and tested during labour and postpartum period.</p>
                                    <p>In the event the baby turns negative at 18 months, the mother and the baby maybe discharged from eMTCT program and continue with Comprehensive care services (CCC).</p>
                                </div>
                            </div>
                        </div>
                    </section>

                </main>

                <!-- QUIZ SECTION -->
                <section class="quiz-section" id="topic-quiz" aria-labelledby="quiz-title">
                    <div class="quiz-header">
                        <div class="quiz-badge">
                            <span class="quiz-icon">üìù</span>
                            <span>Knowledge Check</span>
                        </div>
                        <h2 id="quiz-title" class="quiz-title">Test Your Understanding</h2>
                        <p class="quiz-description">Complete this quiz to assess your comprehension of eMTCT & HIV in Pregnancy.</p>
                    </div>

                    <div class="quiz-container" data-quiz-id="topic-04-quiz"
                        data-quiz-js="../quizzes/topic-04-quiz.js">

                        <div class="quiz-loading">
                            <div class="quiz-spinner"></div>
                            <p>Loading quiz...</p>
                        </div>

                        <div class="quiz-content" hidden></div>

                        <div class="quiz-results" hidden></div>
                    </div>
                </section>

                <!-- BOTTOM NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="topic-03.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>

                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Index</span>
                        </a>

                        <a href="../quiz-hub.html" class="nav-button nav-button--quiz">
                            <span class="nav-icon">üìù</span>
                            <span class="nav-text">All Quizzes</span>
                        </a>

                        <a href="topic-05.html" class="nav-button nav-button--next">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>

            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div id="lightbox" class="lightbox-modal" hidden aria-hidden="true" role="dialog">
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close">&times;</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
    <script src="../js/quiz.js"></script>
</body>

</html>